The distribution of angiotensin converting enzyme genotypes and alleles in the patients with BD and controls
| No | Genotype | Allele | |||
|---|---|---|---|---|---|
| DD | ID | II | D v I | ||
| The values in parentheses in the data for patients with BD are for the patients lacking each criterion: there were no significant differences in the comparison of genotype and allele frequencies between any two groups, including patients with BD v controls, male v female patients with BD, and patients with BD with criterion v without criterion (all p>0.05). | |||||
| For study groups | |||||
| Patients with BD | 70 | 17 (24%) | 28 (40%) | 25 (36%) | 0.44:0.56 |
| Controls | 106 | 20 (19%) | 44 (42%) | 42 (40%) | 0.40:0.60 |
| For patients with BD | |||||
| Male (female) | 27 (43) | 9 (8) | 12 (16) | 6 (19) | 0.56:0.44 (0.37:0.73) |
| Genial ulcerations | 61 (9) | 13 (4) | 26 (2) | 22 (3) | 0.43:0.57 (0.56:0.44) |
| Skin lesions | 65 (5) | 15 (2) | 26 (2) | 24 (1) | 0.43:0.57 (0.60:0.40) |
| Ocular lesions | 20 (50) | 5 (12) | 6 (22) | 9 (16) | 0.40:0.60 (0.46:0.54) |
| Positive pathergy test | 24 (46) | 4 (13) | 10 (18) | 10 (15) | 0.37:0.63 (0.48:0.52) |
| Intestinal lesions | 16 (54) | 2 (15) | 9 (19) | 5 (20) | 0.41:0.59 (0.45:0.55) |
| Peripheral arthritis | 16 (54) | 6 (11) | 6 (22) | 4 (21) | 0.56:0.44 (0.41:0.59) |
| Vascular lesions | 11 (59) | 2 (15) | 5 (23) | 4 (21) | 0.41:0.59 (0.45:0.55) |
| CNS lesions | 7 (63) | 2 (15) | 2 (26) | 3 (22) | 0.43:0.57 (0.44:0.56) |
| Severe manifestations | 27 (43) | 5 (12) | 12 (16) | 10 (15) | 0.41:0.59 (0.46:0.54) |
| Positivity of HLA-B51 | 37 (33) | 9 (8) | 13 (15) | 15 (10) | 0.42:0.58 (0.47:0.53) |